What are the typical acute procedural effects and therapeutic clinical responses to transcranial magnetic stimulation (TMS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Typical Responses to Transcranial Magnetic Stimulation (TMS)

TMS produces both immediate procedural effects (primarily transient headache and scalp discomfort) and therapeutic responses that emerge over 4-6 weeks of treatment, with response rates of 56-58% and remission rates of 26-37% in treatment-resistant depression.

Acute Procedural Effects

Common Immediate Side Effects

  • Transient headaches and scalp discomfort are the most frequently reported acute effects during and immediately after TMS sessions 1
  • These adverse events are typically mild to moderate in intensity and demonstrate a predictable time course of resolution 1
  • The discontinuation rate due to adverse events is low (4.5%) during acute treatment, indicating good tolerability 1

Safety Profile

  • No seizures or deaths have been reported in comprehensive safety studies involving over 10,000 cumulative treatment sessions 1
  • Auditory threshold and cognitive function remain unchanged with TMS treatment 1
  • The procedure is well-tolerated with a low incidence of complications, making it suitable for outpatient administration 1, 2

Therapeutic Clinical Responses

Depression Treatment Outcomes

  • Response rates range from 41.5-58% depending on assessment method (patient-reported vs. clinician-assessed) 3
  • Remission rates range from 26.5-37.1% across different measurement scales 3
  • Mean improvement in Clinical Global Impressions-Severity scores is -1.9 points from baseline to end of acute treatment (P < .0001) 3

Time Course of Therapeutic Response

  • Standard treatment requires daily sessions for 4-6 weeks to achieve therapeutic benefit 4, 2
  • Accelerated protocols delivering 15 sessions over 2 days show response rates of 43% immediately post-treatment, with 36% maintaining response at 3 and 6 weeks 4
  • Improvements in depression and anxiety persist for at least 6 weeks following treatment completion 4

Protocol-Specific Effects on Cognitive Processing

Frequency-Dependent Effects

  • 5 Hz stimulation specifically disrupts reaction time in cognitive tasks 5
  • Continuous theta burst stimulation (cTBS) accounts for nearly half of offline protocols used in research settings 5
  • Different frequencies produce variable effects on cognitive accuracy and processing speed, with frequency-specificity being a clear determinant of effect size 5

Online vs. Offline TMS Effects

  • Two-thirds of experimental protocols employ offline procedures (stimulation before task), while one-third use online TMS (stimulation during task) 5
  • Online rTMS can both up-regulate and down-regulate network function during cognitive tasks, either enhancing or disrupting performance depending on parameters 5
  • Inter-trial interval (ITI) duration significantly influences outcomes: shorter ITI disrupts accuracy while longer duration may enhance it 5

Clinical Applications Beyond Depression

Expanding Indications

  • TMS shows therapeutic utility in obsessive-compulsive disorder, bipolar disorder, schizophrenia, cognitive function disorders, and post-traumatic stress disorder 6
  • There is growing interest in combining rTMS with concurrent behavioral interventions (cognitive behavioral therapy, exposure therapy) for neuropsychiatric disorders 5
  • The treatment is increasingly used as an alternative for patients unable to benefit from initial antidepressant medication 3

Common Pitfalls and Caveats

Technical Considerations

  • Two-thirds of TMS intensities are dosed proportional to individual resting motor threshold (RMT), while one-fifth use active motor thresholds (AMT) 5
  • Neuronavigation using MRI guidance is employed in more than half of studies to ensure accurate targeting 5
  • Many studies remain underpowered, with median sample sizes of only 5 subjects per condition when adjusted for multiple experimental conditions 5

Patient Selection and Expectations

  • Patients in clinical practice typically have failed an average of 2.5 adequate antidepressant trials before receiving TMS 3
  • Adherence rates in real-world settings show 36% of patients may not complete all follow-up visits in accelerated protocols 4
  • The low rate of serious adverse events (primarily increased suicidal ideation in isolated cases) makes TMS a safe option, though monitoring remains essential 4

References

5
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

In a 23‑year‑old woman with dysuria, burning and tearing sensation during and after intercourse, should she be referred to a gynecologist first or a urologist?
What is the most appropriate initial evaluation and management for a 26‑year‑old woman with a 2‑3‑week history of severe right‑breast pain radiating to the shoulder and neck, no palpable mass, skin changes, nipple discharge, or systemic symptoms, and a recent cessation of breastfeeding?
In a 15‑year‑old male with persistent left lower‑quadrant abdominal tenderness and bruising, right‑sided back pain radiating to the ribs, and new left great‑toe stabbing pain with tingling after a recent appendectomy, what imaging studies and medical management are indicated?
How should a 23-year-old male presenting with dysuria and urethral discharge be evaluated and treated?
Which antiviral is appropriate when the specific viral infection, patient age, comorbidities, and organ function are unknown?
What volume of low‑osmolarity oral rehydration solution (ORS) should be given to a child with dehydration based on their weight?
Is co‑amoxiclav (amoxicillin + clavulanic acid) safe to use during pregnancy?
When is the optimal time to treat Hymenolepis nana infection during pregnancy?
What is the recommended management for epiploic appendagitis?
What should be done if a patient's cardiac troponin level doubles within a three‑hour period?
Which direct oral anticoagulant (DOAC) is contraindicated in patients with severe hepatic failure (Child‑Pugh class C)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question